Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04072536
Other study ID # 2019-A00476-51
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 3, 2019
Est. completion date June 18, 2019

Study information

Verified date November 2019
Source Pôle Saint Hélier
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.


Description:

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.

Each patient included will test a wheelchair equipped with a collision avoidance assistance module in 2 conditions, assistance activated or not. This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date June 18, 2019
Est. primary completion date June 18, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Aged over 18,

- Having freely consented to participate in the study,

- suffering from neurological disorders such as cerebro-lesion or neuro-degeneration,

- Having benefited from a prescription of electric wheelchair and circulating in an electric wheelchair for more than 3 months,

- of which the electric wheelchair is the main mode of transport,

- The physical measurements (weight, height) are compatible with the use of the electric wheelchair chosen for the development of the robotics assistance module.

Exclusion Criteria:

- Understanding difficulties preventing the realization of the protocol,

- Motor disorders of the upper limb requiring additional driving technical assistance,

- Patient having expressed difficulties impacting his safety of sedan and / or exterior.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Electric wheelchair with activated assistance module
This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance
Electric wheelchair with assistance module not activated
This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with no activated assistance

Locations

Country Name City State
France Pôle Saint-Hélier Rennes Bretagne

Sponsors (1)

Lead Sponsor Collaborator
Pôle Saint Hélier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of collision The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. Day 1
Primary Number of collision The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. Day 8
Primary Number of collision The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. Day 15
Secondary Driving Speed Speed measured by the completion time of the course with and without activation of the assistance system on the different circuits Day 1, Day 8 and Day 15
Secondary Wheelchair Skill Test Driving performance measured by the Wheelchair Skill Test items corresponding to the different courses, with and without activation of the assistance system Day 1, Day 8 and Day 15
Secondary NASA-Task Load Index The cognitive load of tests under both conditions will be measured by the NASA-Task Load Index. It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity. Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance) Day 1, Day 8 and Day 15
Secondary Ease of Use Questionnaire The satisfaction of the use of the electric wheelchair under the conditions will be evaluated by the self-questionnaire Ease of Use Questionnaire. It measures the subjective usability of a product or service. It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction. The questionnaires were constructed as seven-point Likert rating scales. Users were asked to rate agreement with the statements, ranging from strongly disagree (1) to strongly agree (7). Day 1, Day 8 and Day 15
Secondary UTAUT (Unified theory of acceptance of technology) questionnaire Questionnaire of acceptability / acceptance of the tool and its use by patients based on the Unified Theory of Acceptance and Use Technology (UTAUT). Day 1, Day 8 and Day 15
See also
  Status Clinical Trial Phase
Completed NCT01589289 - Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC Phase 3
Completed NCT00010881 - Oregon Center for Complementary and Alternative Medicine in Neurological Disorders N/A
Recruiting NCT04461821 - Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
Completed NCT04094571 - Muscle Delay Characterization N/A
Recruiting NCT02795052 - Neurologic Stem Cell Treatment Study N/A
Completed NCT02219269 - A Complex Contraception Registry N/A
Completed NCT00122174 - Stress-Busting Program for Caregivers of Patients With Neruological Diseases N/A
Recruiting NCT01524276 - Product Surveillance Registry
Completed NCT00532571 - Effects of Coenzyme Q10 in PSP and CBD Phase 2/Phase 3
Completed NCT05830981 - Valproic Acid Use in Patients With Neurological Disorders
Completed NCT01754168 - Amyloid Beta and Cognition in Parkinson Disease N/A
Completed NCT02780531 - Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
Completed NCT01858350 - Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation N/A
Suspended NCT05212727 - Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
Recruiting NCT01266382 - The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders N/A